RELCOF PE (Relcof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
This pill with imprint "RELCOF PE" is White, Capsule-shape and has been identified as Relcof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg. It is supplied by Burel Pharmaceuticals, Inc..
RelCof PE is used in the treatment of rhinitis; nasal congestion and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. RelCof PE chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- RELCOF PE
- chlorpheniramine maleate 8 mg / methscopolamine nitrate 2.5 mg / phenylephrine hydrochloride 20 mg
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Burel Pharmaceuticals, Inc.
- National Drug Code (NDC):
More about RelCof PE (chlorpheniramine / methscopolamine / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.